drugset / Trial / NCT00003015

Carboplatin Plus Vincristine in Treating Children and Adolescents With Low Grade Glioma

NCT00003015 ↗

Phase 3 Unknown 200 enrolled International Society of Pediatric Oncology
Treatment

Summary

RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining more than one drug may kill more tumor cells. PURPOSE: Randomized phase III trial to compare the effectiveness of carboplatin plus vincristine in treating children and adolescents with low grade glioma.

Timeline

Start
1997-01
Primary completion
—
Completion
—

Publications

  • Results Gnekow AK, Perilongo G, Zanetti I, et al.: Single dose carboplatin and vincristine (VER) for progressive low-grade glioma (LGG) in childhood. A SIOP/GPOH study. [Abstract] International Symposium on Pediatric Neuro-Oncology, May 18-21, 1994, Houston, Tx. A-89, 1999.

Drugs

EvaluationDrugModalityDoseRoute
Subject Carboplatin Small molecule — Intravenous
Subject Vincristine Small molecule — Intravenous